Re-entry illustrations will haunt industry

Article Abstract:

Life insurance agents using re-entry values to compare the benefits of different term life policies are misleading consumers. Eventually the government or the courts may intervene on behalf of consumers, unless the industry stops making reference to re-entry values. Alternatively, agents should compare current or guaranteed renewal premiums for term life. Also, consumers may perceive re-entry values as renewal premiums, which they are not.

Column

---

Riders can benefit both agent and prospect

Article Abstract:

Riders on life insurance policies enable agents to expand coverage and create policies tailored to the needs of policyholders. Riders vary in cost and restrictions and are available for accidental death benefits, waiver of premium, guaranteed insurability and to add coverage for a spouse or child. Insurance agents should explain available riders to clients, thus eliminating exposure to lawsuits.

Product information

---

Selling to America's rainbow

Article Abstract:

Insurance companies are realizing the potential of marketing products to long-ignored ethnic populations. Some minority agents have established their own agencies and brokerages, while others have moved to companies with strong multicultural marketing programs. Equitable Life Assurance Society of the US recruits minority agents through ethnic festivals, trade shows and seminars.

Demographic aspects, Minorities, St. Paul Fire and Marine Insurance Co.

Similar abstracts:

• Abstracts: Demutualization's next phase. An industry under pressure. Life insurers try to change with the times
• Abstracts: The Consumer Bill of Rights. How will health insurance reform affect employees and employers in the future? Will ERISA block substantive health reform?
• Abstracts: Few sheriffs on the wild, wild Internet. Insurers venture onto the Internet web. Imaging can improve service, cut costs
• Abstracts: The new era in catastrophe claims: a reinsurer's perspective. Sorry boss - the cycle did it!
• Abstracts: Changes continue for di insurers. Don't rush to mandate unproven therapy coverage; experimental treatments can hurt patients and often put insurers in a quandary over whether to reimburse

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.